Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

Shire Goes Shopping After AbbVie Deal Falls Through

Can This One Man And His Tiny Biotech Stop Ebola?

U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical's ZMapp Ebola Plans

Exelixis, Inc. To Vacate Most Of Its South San Francisco Office Space

Here???s What An AbbVie-Split Might Mean For Massachusetts

Eli Lilly and Company To Shut Down One Puerto Rico Plant, 100 People Affected

The Top Selling Biologic Drugs

Repros Therapeutics Inc. Shares Tank On Drug Application Setback

Abbott Laboratories Created 400 New Jobs With New Facility In India

Canaan Closes $675 Million Fund With An Eye For Biotech And Medtech Startups

Are Male Brains Wired To Ignore Food For Sex? University of Rochester Medical Center Study

Honeysuckle Tea Can Treat Influenza A Viruses, And Possibly Ebola, Study

How Omega-6 Fatty Acids Lower Bad Cholesterol, Innsbruck Medical University Study

Roche, Merck & Co. Extend Immunotherapy Battle To Breast Cancer

Novartis AG Psoriasis Drug Secukinumab Benefits Outweighs Risk: FDA Staff

Drinking Red Wine May Help Treat Osteoporosis, Aarhus University Study

Stimulant Found In Unapproved Diet Supplements Could Cause Heart Attacks

Lawyers Have Documents That Prove Allergan Inc. Misled Investors About Valeant:

Insulin Biotech Dance Biopharma Withdraws $75 Million IPO

Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2%

AbbVie Still A Buy Despite Shire Fallout, Says Analyst

Cowen and Company: Best Buys, Favorable Biotech Outlook Remain

Astellas Pharma Inc., CoMentis, Inc. Terminate Alzheimer's Agreement

Cadila Healthcare Recalls Blood Pressure Drug In The U.S.

Novartis AG's Leukemia Drug CTL01 Clears Cancer In 90 Percent Of Patients

AbbVie Board Officially Abandons $55 Billion Merger

How Big Pharma Made Us Hypochondriacs

Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond

Berkeley's Aduro Biotech Strikes $817 Million Lung Cancer Pact With Janssen Biotech Inc.

InterMune, Inc. Wins FDA Approval For Lung Drug At Center Of Roche Deal

Ex-Merck & Co. Analyst Charged With Passing Merger Tips To Friend

Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev

100 New Jobs On Horizon At

Shire Plummets As AbbVie Reconsiders $55 Billion Takeover Bid

Atara Biotherapeutics Prices IPO Below The Range At $11 A Share

Agios Pharmaceuticals Smart Buy Ahead Of Cancer Data: Citi

Roche Lucentis, Regeneron Eylea Continue To Battle It Out In Eye Market

Gilead Sciences, Inc. Nervous As Johnson & Johnson Looks To Remain Competitive In Hepatitis C Market

Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials

AstraZeneca PLC Strengthens Partnership With The University of Cambridge

Ranbaxy Laboratories To Pay $40 Million To Settle Texas Medicaid Pricing Litigation

Ex-Mayo Clinic Exec Accused Of Stealing Trade Secrets

Peanut Allergy Biotech DBV Technologies Sets Terms For $98 Million U.S. IPO

Novartis AG Suspends Commissioning Of New $150 Million Plant

GlaxoSmithKline Expands In North Carolina With Hiring Spree

Highland Therapeutics Snags $25 Million Financing

Bone Biotech PolyPid Ltd. Files For A $24 Million IPO

Homeopathic Medicine Isn???t Medicine: Science Babe Swallows 50 Sleep Pills To Prove It

World's Top CEOs—Which Pharma Chiefs Make The List?

Another Diet Myth Debunked: Gradual Weight Loss No Better Than Rapid Weight Loss, University of Melbourne Study

Tumors Might Grow Faster At Night, Weizmann Institute of Science Study

Exercise May Be The Best Anti-Aging Pill, Columbia University Study

New Evidence Linking Autism To Air Pollutants Discovered, Researcher Reveals

Fish Oil Supplements Have Little Effect On Irregular Heartbeat, Montreal Heart Institute Study

Ebola Outbreak Boosts Odds Of Mutation Helping It Spread, University of California, San Francisco (UCSF) Study

Binge Drinking May Alter Your Genes, University of Missouri Study

Scientists Inch Closer To Alzheimer's Origins, Massachusetts General Hospital Study

Apple, Will Pay For Female Workers To Freeze Eggs

Will An FDA Policy Shift On Fixed-Dose Drug Approvals Anger Pharma?

Biotech's Builder: How Pharma's Landlord Could Benefit From The Drug Boom

2nd Health Care Worker Tests Positive For Ebola At Dallas Hospital

Largest Biotech IPO Yet Could Be Derailed By Forward Pharma, Biogen Idec Patent Fight

Analysts Still See AstraZeneca PLC As Viable Takeover Target

Walking Dead: Biotech "Zombie" Companies And Why They Are Failing

Orexigen Therapeutics, Inc. Pockets $100 Million Milestone Payment From Takeda Pharmaceutical Co. Ltd.

FDA Staff Recommend Pfizer Keep Its Black Box Warnings For Chantix

Booming Alexion Pharmaceuticals Inc. Eyes European Headquarters In Zurich On Expansion Push

Geographic Split Likely For GlaxoSmithKline Mature Drugs Sale

UBS: Gilead Sciences, Inc. Remains Solid Buy Despite Irish Tax Changes, Price War

Cosmo Pharmaceuticals S.p.A. Plans To Move Its Management To Ireland

Navidea Biopharmaceuticals Brings In A New CEO

ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma

Successful Spin-Out of From The And Funding By The With EURO 5.9 Million

The Cost Of A Drug That Regrew A Little Girl's Bones

AstraZeneca PLC Holds Its Breath As European Regulators Mull Cancer Drug Fate

Core Team At Ranbaxy Laboratories U.S. Unit Resigned: Report

Nikki Haley???s Nephron Pharmaceuticals Problem Deepens

Selecta Biosciences, Inc. Announces More Than $20 Million In Equity Funding

Zynerba Reels In $13 Million

West Pharmaceutical Services Announces CEO Retirement And Succession Plan

Bruno Lucidi Appointed Permanent CEO Of Karolinska Development AB

Cannabis Biopharma GW Pharmaceuticals Sees Disappointing Data For Colitis Drug

FDA Approves Gilead Sciences, Inc.'s New Hepatitis C Drug Harvoni

Tekmira's Partner Reports Positive Clinical Data For LNP-Enabled Patisiran

Mylan Inc. Recalls Certain Lots Of Mylan-Nitro Sublingual Spray

Could Vitamin D Make Childbirth Less Painful? Cedars-Sinai Medical Center Study

Treating Cancer: University of Iowa Biologists Find Gene That Could Stop Tumors In Their Tracks

Light-Activated Drug Could Reduce Side Effects Of Diabetes Medication, Imperial College London Study

Chemical Derived From Broccoli Sprouts Shows Promise In Treating Autism, Johns Hopkins University School of Medicine Study

Found: Closest Link To Eve, Our Universal Ancestor, Study

Rigontec GmbH???s RNA-Based Immunotherapeutics Grabs $11M In Series A Round

New Irish Tax Rules Won???t Faze Biotech: Analyst

When Firms Missed Job Goals, Relaxed Rules

Animal Testing: Hard Choices Loom As Biosimilars Boom

Becton, Dickinson and Company To Lay Off 60 In San Jose Unit

Life Sciences Industry Gets Traction In Greenville

Bicycle Therapeutics Limited Wins $32M To Finance Oncology Pipeline

PuriCore's CEO To Retire

Ex-Dendreon Corporation CEO Working On New Cancer Drug Startups

Neil Woodford Increases Bet On Stem Cell Therapies

Embattled Wilex AG Sells Unnamed Tumor Drug To Roche For $65.8M

Monsanto Company Announces Major Losses After Settling Environmental Suit

Raze Therapeutics Snags $24M For Cancer Drugs

CDC Foundation Receives $25 Million Donation From Mark Zuckerberg And Dr. Priscilla Chan For Ebola Response

Glut Of Postdoc Researchers Stirs Quiet Crisis In Science

Retrophin Announces Divestment Of Non-Core Assets To

ORYZON Genomics Will Be Expanding, Hiring In Cambridge, Says CEO

Novartis AG's Secukinumab Has Consistent Activity In Psoriasis

Ohr Pharmaceutical Announces Successful End Of Phase 2 Meeting With The FDA On Squalamine Eye Drops (OHR-102) In Wet AMD

4000 Deaths And Counting: The Ebola Epidemic In 4 Charts

Roche Outlines New Jersey Site Remediation

Thyroid Carcinoma: Biomarker Reveals Cancer Cause, Helmholtz Zentrum Munchen Study

Rats Of New York And The Diseases They Carry, Columbia University Study

Pfizer's Palbociclib Granted FDA Priority Review

Obesity May Speed Aging Of The Liver, University of California, Los Angeles (UCLA) Study

Cold Temperatures Can Help Weight Loss, University of Kentucky Study

Meet The Man Who Wants To Build UK's Biggest Biotech

Doctors Get Fewer Free Lunches From Drug Firms In MA Compared To The Rest Of The Country

Sanofi Looks To Rival AstraZeneca PLC For New UK & Ireland Head

Biotech???s Biggest Hirers Of The Last 5 Years

SD's Cosmederm Bioscience Banks $50 Million

Ariad Pharmaceuticals, Inc.???s Says He???s "Absolutely" Secure In His Role As CEO

Mali Health Workers Get Experimental GlaxoSmithKline Ebola Vaccine

FDA Believes Sun Pharmaceutical Industries Ltd Did Not Implement An Effective Action Plan For Metformin Recall

NPPA Slaps Novartis AG With Penalty Fine

222


    Read more..